about
How active are our children? Findings from the Millennium Cohort Study.Predictors of non-response in a UK-wide cohort study of children's accelerometer-determined physical activity using postal methodsModeling normative kinetic perimetry isopters using mixed-effects quantile regression.Estimation of regression quantiles in complex surveys with data missing at random: An application to birthweight determinants.Quality control methods in accelerometer data processing: defining minimum wear timeQuality control methods in accelerometer data processing: identifying extreme countsQuantile regression for longitudinal data using the asymmetric Laplace distribution.Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.Environmental influences on children's physical activity.Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.Survival from cancer in teenagers and young adults in England, 1979-2003Geographical and temporal distribution of cancer survival in teenagers and young adults in England.Diagnosis and assessment of Crohn's disease: the present and the future.Anthropometric Charts for Infants Born Between 22 and 29 Weeks' Gestation.Cancer at ages 15-29 years: the contrasting incidence in India and England.Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.Testing for unusual aggregation of health risk in semiparametric models.Pre-clinical Crohn's disease: diagnosis, treatment and six year follow-up.Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.Using functional data analysis to understand daily activity levels and patterns in primary school-aged children: Cross-sectional analysis of a UK-wide study.Relationship between height at diagnosis and bone tumours in young people: a meta-analysis.Morbidity and Mortality in Small for Gestational Age Infants at 22 to 29 Weeks' Gestation.Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003.Transparency in a world of complexity: Basic guidelines for improved statistical reporting.Median percent change: a robust alternative for assessing temporal trends.Associations between children’s behavioural and emotional development and objectively measured physical activity and sedentary time: Findings from the UK Millennium Cohort StudyChanges in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's diseaseThe contrasting age-incidence patterns of bone tumours in teenagers and young adults: Implications for aetiologyIn-Hospital Outcomes in Large for Gestational Age Infants at 22-29 Weeks of GestationMultiple Imputation for Bounded VariablesNeonatal and fetal growth charts to identify preterm infants <30 weeks gestation at risk of adverse outcomesA family of linear mixed-effects models using the generalized Laplace distributionQuantile contours and allometric modelling for risk classification of abnormal ratios with an application to asymmetric growth-restriction in preterm infantsOpioid Prescription Patterns for Adults With Longstanding Disability and Inflammatory Conditions Compared to Other Users, Using a Nationally Representative SampleMultistate quantile regression modelsAn increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patientsModelling and estimation of nonlinear quantile regression with clustered dataAdditive quantile regression for clustered data with an application to children's physical activity
P50
Q28681543-6992CA2B-3D7D-4A94-8514-4FFD0E243139Q28709447-6D073648-B66C-449F-8B01-3A929B3662CDQ30489242-3D3D1E84-D174-44DD-9E83-3DECE483A37DQ30619696-721C0967-B6C1-4A5A-88B1-34780335B056Q30653389-86DAE3D5-D7C8-46EB-BC7A-003FBB4AF148Q30740494-0462BB10-7F16-487C-9FAA-B90286302701Q33240968-C0CDDA40-9E65-4C94-A636-E7D745492029Q33926729-F37E229C-7663-496C-AA49-0809756785FFQ34817918-D2670359-DE74-4B57-990B-0F9189054A68Q35659059-9A65A422-95F9-4096-A48C-E6871A1FF139Q36859225-BB1EA230-57A2-4777-B905-2D750F812E28Q37457757-2DCD2E7B-BB11-49D6-9593-49A62334DF3CQ37812389-9D882076-DED2-4A36-B4A7-650C58A948C1Q38784440-96579D2E-7BFA-4B7A-B5F6-45B3B309B497Q39954978-4D7658E2-E143-486C-8CE1-94A6C12D912BQ42632507-C25B47E1-CCD6-4FCD-AD8A-029C57817260Q43354056-1C4477C4-3257-4508-95F4-EAD239AD1219Q44992549-348ADD77-1BBD-42EA-A1DB-220A835B873AQ44997544-C8D0044D-3A23-488C-B166-7A4E100A0D63Q45387338-DF26E4E5-4FCB-4657-AAFD-A2A25A75DAEEQ46301132-E72EF1FA-5D46-413D-9F6F-DDDE57CCFC03Q47559213-B76206FC-EF24-448E-A798-8239F2692068Q48288196-8748F928-69D2-4506-8F42-683B23BF9B3AQ50714723-A6E9882C-D78B-45AF-879E-9017FD2343DEQ51165987-6157FACE-C6FD-4082-BD7A-63D7772E8113Q60240319-34670C3C-DF1C-4406-A626-C8F6A0FD1A71Q82257401-04555504-9F2C-4E00-A8FF-C4BFEA49026CQ82816860-9F70C109-1210-452C-9F69-22ABC3FDC576Q82985120-ACED4E6B-2C79-484D-9AA5-438D537F12E8Q88309991-03FDEA0A-BAA2-42D7-BB57-17D9C071440BQ88489289-5588694A-1574-4209-BE56-C06390C9817CQ88641514-03315876-5FFE-4718-BA8F-44083F6A65F3Q90194423-F6738F53-1684-4FF3-A0BF-08F0CEF31725Q90210620-5BCDEC5C-CB4B-4483-BC0F-F64DF167B57FQ90918227-8F7DB968-C9B9-44CF-9694-AAA0D2745FF0Q91336719-5E14A58D-1C24-4F58-944B-7E309806E232Q91523450-4294F1A1-580F-4D1A-8CD0-F0061C257C3AQ92275152-D79BC231-869A-4778-A0C3-645637E8784FQ92297350-BF1ABD7F-19AF-4415-B040-A2F1CA617E9F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Geraci
@ast
Marco Geraci
@en
Marco Geraci
@es
Marco Geraci
@nl
Marco Geraci
@sl
type
label
Marco Geraci
@ast
Marco Geraci
@en
Marco Geraci
@es
Marco Geraci
@nl
Marco Geraci
@sl
prefLabel
Marco Geraci
@ast
Marco Geraci
@en
Marco Geraci
@es
Marco Geraci
@nl
Marco Geraci
@sl
P108
P106
P21
P31
P496
0000-0002-6311-8685